| HRES1 |
P13985
|
HTLV-1 related endogenous sequence
|
|
|
0.636 |
0.615 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| IFNB1 |
P01574
|
interferon beta 1
|
|
|
0.421 |
0.846 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| DBA2 |
|
Diamond-Blackfan anemia 2
|
|
|
0.599 |
0.731 |
| MIR146A |
|
microRNA 146a
|
|
|
0.398 |
0.885 |
| MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
| PSS |
|
Potocki-Shaffer syndrome
|
|
|
0.608 |
0.654 |
| DNASE1 |
P24855
|
deoxyribonuclease 1
|
|
7.0E-21 |
0.505 |
0.846 |
| PADI4 |
Q9UM07
|
peptidyl arginine deiminase 4
|
|
4.6E-16 |
0.494 |
0.808 |
| APOH |
P02749
|
apolipoprotein H
|
|
1.6E-15 |
0.563 |
0.769 |
| MMP3 |
P08254
|
matrix metallopeptidase 3
|
Enzyme
|
5.7E-15 |
0.408 |
0.885 |
| BLK |
P51451
|
BLK proto-oncogene, Src family tyrosine kinase
|
Kinase
|
8.3E-14 |
0.585 |
0.769 |
| IFI16 |
Q16666
|
interferon gamma inducible protein 16
|
Transcription factor
|
1.8E-11 |
0.603 |
0.769 |
| GSN |
P06396
|
gelsolin
|
Cellular structure
|
3.9E-11 |
0.475 |
0.885 |
| TAP2 |
Q03519
|
transporter 2, ATP binding cassette subfamily B member
|
Transporter
|
6.9E-11 |
0.517 |
0.808 |
| RBM45 |
Q8IUH3
|
RNA binding motif protein 45
|
|
2.1E-10 |
0.383 |
0.846 |
| HLA-DPB1 |
P04440
|
major histocompatibility complex, class II, DP beta 1
|
Immune response
|
5.3E-10 |
0.453 |
0.923 |
| SOAT1 |
P35610
|
sterol O-acyltransferase 1
|
Enzyme
|
7.4E-10 |
0.424 |
0.846 |
| TRIM21 |
P19474
|
tripartite motif containing 21
|
|
3.4E-09 |
0.485 |
0.808 |
| ADIPOQ |
Q15848
|
adiponectin, C1Q and collagen domain containing
|
|
4.6E-09 |
0.376 |
0.885 |
| PRL |
P01236
|
prolactin
|
Signaling
|
2.9E-07 |
0.406 |
0.885 |
| AICDA |
Q9GZX7
|
activation induced cytidine deaminase
|
Enzyme
|
9.2E-06 |
0.463 |
0.885 |